PlainRecalls
FDA Drug Low Class III Terminated

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32

Reported: November 11, 2020 Initiated: October 26, 2020 #D-0066-2021

Product Description

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32

Reason for Recall

Subpotent

Details

Units Affected
23,616 blister packs
Distribution
Product was distributed nationwide
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 23,616 blister packs.
Why was this product recalled?
Subpotent
Which agency issued this recall?
This recall was issued by the FDA Drug on November 11, 2020. Severity: Low. Recall number: D-0066-2021.